4 completed, 2 active not recruiting, 2 withdrawn. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow Rhabdoid Tumor of the Kidney: new trials by email Literature Review of Rhabdoid Tumor of the Kidney trials Research Report on Rhabdoid Tumor of the Kidney
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers Nivolumab, Ipilimumab - Malignant Rhabdoid Tumor, Rhabdoid Tumor of the Kidney | Phase 2 | Active not recruiting | Dana-Farber Cancer Institute | 30 | 2020-08-14 | 2026-10-20 |
| Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study Biospecimen Collection, Bone Scan, Cabozantinib - Clear Cell Renal Cell Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 1175 | 2019-06-07 | 2026-10-22 |
| Studying Biomarkers in Samples From Younger Patients With Kidney Cancer Laboratory Biomarker Analysis - Childhood Kidney Neoplasm, Clear Cell Renal Cell Carcinoma | Withdrawn | Children's Oncology Group | 2012-08-22 | 2018-08-07 | ||
| Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor Laboratory Biomarker Analysis - Childhood Atypical Teratoid/Rhabdoid Tumor, Rhabdoid Tumor of the Kidney | Withdrawn | Children's Oncology Group | 2011-11-01 | 2018-08-07 | ||
| Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor DNA methylation analysis, gene expression analysis, microarray analysis - Clear Cell Sarcoma of the Kidney, Recurrent Wilms Tumor and Other Childhood Kidney Tumors | Completed | Children's Oncology Group | 185 | 2010-05-01 | 2016-05-19 | |
| Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Dactinomycin, Doxorubicin Hydrochloride, Radiation Therapy - Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome | Phase 3 | Completed | Children's Oncology Group | 249 | 2009-08-24 | 2026-06-03 |
| Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Doxorubicin Hydrochloride, Irinotecan Hydrochloride, Conventional Surgery - Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma | Phase 2 | Completed | Children's Oncology Group | 291 | 2006-06-01 | 2017-07-21 |
| Study of Kidney Tumors in Younger Patients Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor | Completed | Children's Oncology Group | 8000 | 2006-02-27 | 2026-05-18 |
Carcinoma, Renal Cell (4) · Wilms Tumor (4) · Nephroma, Mesoblastic (2) · Rhabdoid Tumor (2) · Angiolipoma (1) · Beckwith-Wiedemann Syndrome (1) · Chordoma (1) · Kidney Neoplasms (1) · Lymphatic Metastasis (1) · Oncocytoma, renal (1) · Sarcoma (1)
Neoplasms (8) · Neoplasms by Histologic Type (8) · Neoplasms, Complex and Mixed (7) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Kidney Diseases (6) · Male Urogenital Diseases (6) · Neoplasms by Site (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Urologic Diseases (6) · Urologic Neoplasms (6) · Kidney Neoplasms (5) · Adenocarcinoma (4) · Carcinoma (4)
Dactinomycin (2) · Doxorubicin (2) · Ipilimumab (2) · Nivolumab (2) · Radiation (2) · Radiotherapy (2) · Vincristine (2) · CTLA-4 Antigen (1) · Carboplatin (1) · Congresses as Topic (1) · Cyclophosphamide (1) · DNA Methylation (1) · Etoposide (1) · Gene Expression Profiling (1) · Irinotecan (1)
Children's Oncology Group (6) · Dana-Farber Cancer Institute (1) · National Cancer Institute (NCI) (1)
United States (8) · Puerto Rico (4) · Australia (3) · Canada (3) · New Zealand (3) · Israel (2) · Switzerland (1)
Elizabeth A Mullen (1) · Elizabeth Beierle (1) · Elizabeth Perlman, MD (1) · Jeffrey Dome, MD (1) · Peter F Ehrlich (1) · Simone Sredni (1) · Suzanne Forrest, MD (1) · Tian Zhang (1)
PMID 38396300, PMID 32267967, PMID 35072864, PMID 35304832, PMID 35383907, PMID 37933882, PMID 42657661
U10CA098543 (4), U10CA180886 (2), U10CA180821 (1), UG1CA189958 (1)